ATF3 has been widely reported in the treatment of diseases, such as prevention of cardiac hypertrophy and fibrosis, neuronal axon regeneration after traumatic nerve injury, liver fibrosis treatment, and breast cancer target [44,61,62,63]. This evidence concerns the gene ATF3 and cardiac hypertrophy.